{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:12:28Z","timestamp":1789711948279,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.eclinm.2022.101797","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T07:01:00Z","timestamp":1672902060000},"page":"101797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0039","authenticated-orcid":false,"given":"Rose G.","family":"Bender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Aravkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Ars\u00e8ne","family":"Bita Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ado M.","family":"Bwaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie C.","family":"Galles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Haeuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon I.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"Latt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Mwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.B.","family":"Rogowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa N.","family":"Sbarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed J.D.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avina","family":"Vongpradith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-2331","authenticated-orcid":false,"given":"Claire","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-3186","authenticated-orcid":false,"given":"Jonathan F.","family":"Mosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hmwe H.","family":"Kyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2022.101797_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101797_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib3","author":"Lapeyssonnie"},{"key":"10.1016\/j.eclinm.2022.101797_bib4","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.vaccine.2009.04.062","article-title":"Epidemic meningitis due to group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution","volume":"27","author":"Marc LaForce","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2022.101797_bib5","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/infdis\/jiz336","article-title":"Status of the rollout of the meningococcal serogroup A conjugate vaccine in African meningitis belt countries in 2018","volume":"220","author":"Bwaka","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib6","doi-asserted-by":"crossref","first-page":"S514","DOI":"10.1093\/cid\/civ672","article-title":"Antibody persistence 1\u20135 years following vaccination with MenAfriVac in African children vaccinated at 12\u201323 months of age","volume":"61","author":"Tapia","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib7","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1093\/cid\/civ671","article-title":"Risk assessment and meningococcal A conjugate vaccine introduction in Africa: the district prioritization tool","volume":"61","author":"Cibrelus","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib8","series-title":"National immunization coverage scorecards estimates for 2019","year":"2020"},{"key":"10.1016\/j.eclinm.2022.101797_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(17)30301-8","article-title":"Impact of MenAfriVac in nine countries of the African meningitis belt, 2010\u201315: an analysis of surveillance data","volume":"17","author":"Trotter","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup a meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib11","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1016\/j.vaccine.2017.07.063","article-title":"WHO position paper, Meningococcal A conjugate vaccine: updated guidance, February 2015","volume":"36","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2022.101797_bib12","series-title":"Defeating meningitis by 2030: a global road map","year":"2021"},{"key":"10.1016\/j.eclinm.2022.101797_bib13","first-page":"365","article-title":"Control of epidemic meningitis in countries in the African meningitis belt, 2020 \u2013 Lutte contre la m\u00e9ningite \u00e9pid\u00e9mique dans les pays de la ceinture africaine de la m\u00e9ningite, 2020","volume":"96","year":"2021","journal-title":"Wkly Epidemiol Rec\u00a0= Relev\u00e9 \u00e9pid\u00e9miol hebd"},{"key":"10.1016\/j.eclinm.2022.101797_bib14","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/cid\/civ508","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt","volume":"61","author":"Karachaliou","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib15","series-title":"Guide to introducing meningococcal A: conjugate vaccine into the routine immunization programme","year":"2019"},{"key":"10.1016\/j.eclinm.2022.101797_bib16","first-page":"133","article-title":"Control of epidemic meningitis in countries in the African meningitis belt, 2019 \u2013 Lutte contre la m\u00e9ningite \u00e9pid\u00e9mique dans les pays de la ceinture africaine de la m\u00e9ningite, 2019","volume":"95","year":"2020","journal-title":"Wkly Epidemiol Rec\u00a0= Relev\u00e9 \u00e9pid\u00e9miol hebd"},{"key":"10.1016\/j.eclinm.2022.101797_bib17","first-page":"409","article-title":"Control of epidemic meningitis in countries in the African meningitis belt, 2021 \u2013 Lutte contre la m\u00e9ningite \u00e9pid\u00e9mique dans les pays de la ceinture africaine de la m\u00e9ningite, 2021","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec\u00a0= Relev\u00e9 \u00e9pid\u00e9miol hebd"},{"key":"10.1016\/j.eclinm.2022.101797_bib21","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1093\/infdis\/jiz304","article-title":"Evaluation of the impact of meningococcal serogroup A conjugate vaccine introduction on second-year-of-life vaccination coverage in Burkina Faso","volume":"220","author":"Zoma","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib25","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(08)61869-3","article-title":"Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage","volume":"372","author":"Lim","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101797_bib26","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/cid\/civ551","article-title":"Introduction and rollout of a new group A meningococcal conjugate vaccine (PsA-TT) in African meningitis belt countries, 2010-2014","volume":"61 Suppl 5","author":"Djingarey","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101797_bib28","author":"Sorensen"},{"key":"10.1016\/j.eclinm.2022.101797_bib29","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2016.06.053","article-title":"Monitoring vaccination coverage: defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2022.101797_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(21)00984-3","article-title":"Measuring routine childhood vaccination coverage in 204 countries and territories, 1980\u20132019: a systematic analysis for the Global Burden of Disease Study 2020, release 1","volume":"398","author":"Galles","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101797_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101797_bib32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S1473-3099(17)30419-X","article-title":"Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis","volume":"17","author":"Shearer","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib33","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819001134","article-title":"Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis","volume":"147","author":"Cooper","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.eclinm.2022.101797_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.11604\/pamj.supp.2017.27.3.12182","article-title":"Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach","volume":"27","author":"Nyaku","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.eclinm.2022.101797_bib35","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/infdis\/jiz355","article-title":"Meningococcal meningitis outbreaks in the African meningitis belt after meningococcal serogroup A conjugate vaccine introduction, 2011\u20132017","volume":"220","author":"Fernandez","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187466","article-title":"Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign","volume":"12","author":"Diallo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2022.101797_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0140-6736(21)01337-4","article-title":"Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study","volume":"398","author":"Causey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101797_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67023","article-title":"Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries","volume":"10","author":"Gaythorpe","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.eclinm.2022.101797_bib39","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1080\/21645515.2017.1378841","article-title":"Successful African introduction of a new group A meningococcal conjugate vaccine: future challenges and next steps","volume":"14","author":"LaForce","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eclinm.2022.101797_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/21645515.2017.1412020","article-title":"Vaccine prevention of meningococcal disease in Africa: major advances, remaining challenges","volume":"14","author":"Mustapha","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eclinm.2022.101797_bib41","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa2013615","article-title":"Meningococcal serogroup ACWYX conjugate vaccine in Malian toddlers","volume":"384","author":"Tapia","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2022.101797_bib42","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1093\/infdis\/jiz297","article-title":"Eliminating meningococcal epidemics from the African meningitis belt: the case for advanced prevention and control using next-generation meningococcal conjugate vaccines","volume":"220","author":"Alderson","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101797_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-03043-4","article-title":"Mapping routine measles vaccination in low- and middle-income countries","volume":"589","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2022.101797_bib44","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.vaccine.2013.01.015","article-title":"From Agadez to Zinder: estimating coverage of the MenAfriVacTM conjugate vaccine against meningococcal serogroup A in Niger, September 2010 \u2013 January 2012","volume":"31","author":"Caini","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2022.101797_bib45","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.vaccine.2015.01.043","article-title":"Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso\u2014implications for introduction of PsA-TT into the expanded programme on immunization","volume":"33","author":"Meyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.eclinm.2022.101797_bib46","article-title":"Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2022.101797_bib47","first-page":"38","article-title":"[Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014]","volume":"27","author":"Landoh","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.eclinm.2022.101797_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/cid\/ciy488","article-title":"Antibody persistence at the population level 5 years after mass vaccination with meningococcal serogroup A conjugate vaccine (PsA-TT) in Burkina Faso: need for a booster campaign?","volume":"68","author":"Yaro","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022005260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022005260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:16:44Z","timestamp":1762899404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022005260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S2589537022005260"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101797","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101797"}}